HPSE and lung cancer: Given that patient-derived xenografts (PDX) implanted in immunodeficient mice better resemble the original parent tumor, and that drug responses obtained in PDX models appear highly consistent with responses in patients [23], we established a PDX model system for lung cancer in order to bring anti-heparanase treatment closer to the clinic.